We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBTC icon
301
Grayscale Bitcoin Trust
GBTC
$11.6B
$18.6K ﹤0.01%
+387
New +$20.4K
WTRG icon
302
Essential Utilities
WTRG
$11.7B
$18.6K ﹤0.01%
498
FNDX icon
303
Schwab Fundamental US Large Company Index ETF
FNDX
$27.6B
$18.5K ﹤0.01%
828
CHTR icon
304
Charter Communications
CHTR
$18.3B
$17.9K ﹤0.01%
60
AMLP icon
305
Alerian MLP ETF
AMLP
$13.4B
$17.9K ﹤0.01%
373
NRK icon
306
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$892M
$17.7K ﹤0.01%
1,600
BNTX icon
307
BioNTech
BNTX
$25.6B
$17.7K ﹤0.01%
220
+200
+1,000% +$18.3K
SDY icon
308
State Street SPDR S&P Dividend ETF
SDY
$22B
$17.7K ﹤0.01%
139
LNC icon
309
Lincoln National
LNC
$8.29B
$17.3K ﹤0.01%
555
-12
-2% -$363
FWONK icon
310
Liberty Media Series C
FWONK
$25.5B
$17.2K ﹤0.01%
239
VBR icon
311
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$17.2K ﹤0.01%
94
SCHE icon
312
Schwab Emerging Markets Equity ETF
SCHE
$13B
$17.1K ﹤0.01%
645
ADM icon
313
Archer Daniels Midland
ADM
$39.3B
$16.8K ﹤0.01%
277
+1
+0.4% +$61
IEMG icon
314
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
$16.7K ﹤0.01%
312
+190
+156% +$10K
ARTY
315
iShares Future AI & Tech ETF
ARTY
$3.96B
$16.6K ﹤0.01%
500
+2
+0.4% +$67
LW icon
316
Lamb Weston
LW
$7.56B
$16.5K ﹤0.01%
196
-27,162
-99% -$2.32M
NVO
317
Novo Nordisk
NVO
$202B
$16.3K ﹤0.01%
114
SCHC icon
318
Schwab International Small-Cap Equity ETF
SCHC
$5.76B
$16.2K ﹤0.01%
456
IWR icon
319
iShares Russell Mid-Cap ETF
IWR
$57.1B
$16.2K ﹤0.01%
200
IP icon
320
International Paper
IP
$20.8B
$16.2K ﹤0.01%
376
+204
+119% +$8.29K
PIO icon
321
Invesco Global Water ETF
PIO
$274M
$16.2K ﹤0.01%
400
DD icon
322
DuPont de Nemours
DD
$18.5B
$16.1K ﹤0.01%
159
D icon
323
Dominion Energy
D
$57.7B
$15.9K ﹤0.01%
324
EXPE icon
324
Expedia Group
EXPE
$39.5B
$15.9K ﹤0.01%
126
FLIC
325
DELISTED
First of Long Island Corp
FLIC
$15.8K ﹤0.01%
1,577
+116
+8% +$1.18K

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.